512 related articles for article (PubMed ID: 27087445)
1. Asprosin, a Fasting-Induced Glucogenic Protein Hormone.
Romere C; Duerrschmid C; Bournat J; Constable P; Jain M; Xia F; Saha PK; Del Solar M; Zhu B; York B; Sarkar P; Rendon DA; Gaber MW; LeMaire SA; Coselli JS; Milewicz DM; Sutton VR; Butte NF; Moore DD; Chopra AR
Cell; 2016 Apr; 165(3):566-79. PubMed ID: 27087445
[TBL] [Abstract][Full Text] [Related]
2. Energy Regulation Mechanism and Therapeutic Potential of Asprosin.
Hoffmann JG; Xie W; Chopra AR
Diabetes; 2020 Apr; 69(4):559-566. PubMed ID: 32198197
[TBL] [Abstract][Full Text] [Related]
3. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation.
Lee T; Yun S; Jeong JH; Jung TW
Mol Cell Endocrinol; 2019 Apr; 486():96-104. PubMed ID: 30853600
[TBL] [Abstract][Full Text] [Related]
4. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride.
Zhang L; Chen C; Zhou N; Fu Y; Cheng X
Clin Chim Acta; 2019 Feb; 489():183-188. PubMed ID: 29104036
[TBL] [Abstract][Full Text] [Related]
5. Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue.
Miao Y; Qin H; Zhong Y; Huang K; Rao C
J Endocrinol; 2021 May; 249(2):83-93. PubMed ID: 33705351
[TBL] [Abstract][Full Text] [Related]
6. Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature.
Mazur-Bialy AI
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673009
[TBL] [Abstract][Full Text] [Related]
7. Asprosin is a centrally acting orexigenic hormone.
Duerrschmid C; He Y; Wang C; Li C; Bournat JC; Romere C; Saha PK; Lee ME; Phillips KJ; Jain M; Jia P; Zhao Z; Farias M; Wu Q; Milewicz DM; Sutton VR; Moore DD; Butte NF; Krashes MJ; Xu Y; Chopra AR
Nat Med; 2017 Dec; 23(12):1444-1453. PubMed ID: 29106398
[TBL] [Abstract][Full Text] [Related]
8. Serum asprosin levels and bariatric surgery outcomes in obese adults.
Wang CY; Lin TA; Liu KH; Liao CH; Liu YY; Wu VC; Wen MS; Yeh TS
Int J Obes (Lond); 2019 May; 43(5):1019-1025. PubMed ID: 30459402
[TBL] [Abstract][Full Text] [Related]
9. Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases.
Li X; Liao M; Shen R; Zhang L; Hu H; Wu J; Wang X; Qu H; Guo S; Long M; Zheng H
Mediators Inflamm; 2018; 2018():7375294. PubMed ID: 30524197
[TBL] [Abstract][Full Text] [Related]
10. Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK.
Zhang Y; Zhu Z; Zhai W; Bi Y; Yin Y; Zhang W
Enzyme Microb Technol; 2021 Mar; 144():109737. PubMed ID: 33541572
[TBL] [Abstract][Full Text] [Related]
11. Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome.
Alan M; Gurlek B; Yilmaz A; Aksit M; Aslanipour B; Gulhan I; Mehmet C; Taner CE
Gynecol Endocrinol; 2019 Mar; 35(3):220-223. PubMed ID: 30325247
[TBL] [Abstract][Full Text] [Related]
12. Decreased Circulating Levels of Asprosin in Obese Children.
Long W; Xie X; Du C; Zhao Y; Zhang C; Zhan D; Li Z; Ning Q; Luo X
Horm Res Paediatr; 2019; 91(4):271-277. PubMed ID: 31212299
[TBL] [Abstract][Full Text] [Related]
13. Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes.
Groener JB; Valkanou A; Kender Z; Pfeiffenberger J; Kihm L; Fleming T; Nawroth PP; Kopf S
PLoS One; 2019; 14(9):e0222771. PubMed ID: 31536600
[TBL] [Abstract][Full Text] [Related]
14. Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle.
Jung TW; Kim HC; Kim HU; Park T; Park J; Kim U; Kim MK; Jeong JH
J Cell Physiol; 2019 Nov; 234(11):20888-20899. PubMed ID: 30997682
[TBL] [Abstract][Full Text] [Related]
15. Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion.
Wang Y; Qu H; Xiong X; Qiu Y; Liao Y; Chen Y; Zheng Y; Zheng H
Mediators Inflamm; 2018; 2018():9471583. PubMed ID: 29743813
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.
Mishra I; Xie WR; Bournat JC; He Y; Wang C; Silva ES; Liu H; Ku Z; Chen Y; Erokwu BO; Jia P; Zhao Z; An Z; Flask CA; He Y; Xu Y; Chopra AR
Cell Metab; 2022 Apr; 34(4):549-563.e8. PubMed ID: 35298903
[TBL] [Abstract][Full Text] [Related]
17. Fibrillin-1 and asprosin, novel players in metabolic syndrome.
Summers KM; Bush SJ; Davis MR; Hume DA; Keshvari S; West JA
Mol Genet Metab; 2023 Jan; 138(1):106979. PubMed ID: 36630758
[TBL] [Abstract][Full Text] [Related]
18. Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects.
Farrag M; Ait Eldjoudi D; González-Rodríguez M; Cordero-Barreal A; Ruiz-Fernández C; Capuozzo M; González-Gay MA; Mera A; Lago F; Soffar A; Essawy A; Pino J; Farrag Y; Gualillo O
Front Endocrinol (Lausanne); 2022; 13():1101091. PubMed ID: 36686442
[TBL] [Abstract][Full Text] [Related]
19. Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus.
Diao H; Li X; Xu Y; Xing X; Pang S
J Diabetes Complications; 2023 Nov; 37(11):108614. PubMed ID: 37769508
[TBL] [Abstract][Full Text] [Related]
20. Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus.
Baykus Y; Yavuzkir S; Ustebay S; Ugur K; Deniz R; Aydin S
Peptides; 2019 Oct; 120():170132. PubMed ID: 31400492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
